alexa Ocular Neostigmine Drops for Diagnosing Myasthenia Gravis | OMICS International | Abstract
ISSN: 2155-9562

Journal of Neurology & Neurophysiology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)


Ocular Neostigmine Drops for Diagnosing Myasthenia Gravis

Mustafa A Salih1*, Mohamed A Salih2, Ali A Mustafa3, Darren T Oystreck4, Kamal M Attia5, Sara M El-Sadig6, Ahlam A Hamed7, Waseem M Hajjar8 and Thomas M Bosley4

1Division of Pediatric Neurology, College of Medicine, King Saud University, Riyadh, Saudi Arabia

2Sinnar Hospital and Kush Eye Center, Omdurman, Sudan

3Basic Medical Sciences Department, College of Medicine, King Fahad Medical City, Riyadh, Saudi Arabia

4Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia

5Department of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia

6Department of Medicine, Faculty of Medicine, University of Khartoum, Sudan

7Department of Pediatrics and Child Health, Faculty of Medicine, University of Khartoum, Sudan

8Department of Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia

Corresponding Author:
Prof. Mustafa A Salih, MD
Department of Pediatrics
College of Medicine, Saudi Arabia
Tel: +966 1 4679728
Fax: +966 1 4679643
E-mail: [email protected]

Received date: February 07, 2013; Accepted date: March 26, 2013; Published date: March 30, 2013

Citation: Salih MA, Salih MA, Mustafa AA, Oystreck DT, Attia KM, et al. (2013) Ocular Neostigmine Drops for Diagnosing Myasthenia Gravis. J Neurol Neurophysiol S11:004. doi:10.4172/2155-9562.S11-004

Copyright: © 2013 Salih MA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Introduction: A variety of tests have been devised for the diagnosis of myasthenia gravis (MG). The best known
of these (Tensilon test, using intravenous edrophonium chloride) may cause serious complications (bradycardia and
syncope) dictating cardiac monitoring during the procedure. Ocular neostigmine drops, a simple procedure, may
significantly reduce the risk of diagnostic testing for possible MG.
Method: To investigate its efficacy, the miotic effect of neostigmine was explored using 30 rabbits. One drop of
sterile neostigmine solution (2.5 mg/ml) was instilled into the right eye (RE) of each rabbit using the left eye (LE), which
received sterile normal saline, as control. Serial assessments of pupillary size were done. One drop of neostimine was
instilled daily for 7 days to investigate its safety. Six patients (aged 4.5–55y, median=42y, mean=36.4y) with MG had
the same test and were observed for increase of the palpebral fissure height (documented by photography).
Results: At baseline there was no significant difference in the mean [SD] pupillary size of the rabbits between the
RE (7 mm [1.07]) and LE (7 mm [1.07]), p=0.63). Significant miotic effect was observed in the RE compared to the LE
at 30, 60 and 90 minutes (respectively, 4.8 mm [1.86] vs 7.0 mm [1.09], p=0.0001; 4.8 mm [1.86] vs 7.0 mm [1.09],
p=0.0001; and 3.2 [0.76] vs 7.0 [0.0], p=0.013). Administration of one drop of neostimine daily for 7 days caused no
ocular inflammation. All six patients with MG had an observable increase of the palpebral fissure height (documented
by photography) of at least 2 mm, 30 minutes after neostigmine instillation. The response was dramatic in the three
patients with no prior treatment for MG.
Conclusion: Ocular neostigmine drops is a safe, simple and efficient diagnostic test for MG.


Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry


[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version